Topics discussed include proposals for a fee schedule by 2027, employer direction of care, and allowing more providers to provide disability opinions.
Topics discussed include proposals for a fee schedule by 2027, employer direction of care, and allowing more providers to provide disability opinions.
In a DWC meeting, stakeholders spoke regarding the timeline of when a physician evaluates a patient, versus other types of providers.
Healthe attended the April 16th meeting, capturing key updates regarding the pharmacy fee schedule and drug formulary.
Senate Bill 317 originally focused on provider panels, but a recent hearing amended the bill to include a workers’ comp formulary.
The hybrid meeting will cover the pharmacy fee schedule, biosimilars, cannabis coverage, and payments for topical drugs.
Among many changes, the bill would shift the burden of proof to insurers in medical treatment disputes.
The ACOEM cannabis guideline from late January 2025 recommend against medical marijuana for the treatment of pain.
Two bills would allow physicians to dispense “dangerous drugs” directly to injured workers in rural areas.
The updates would incorporate evidence-based revisions to Chronic Pain Guidelines and Cannabis Guidelines from ACOEM.
The proposed bill would have required prior authorization on treatments above $1,500, instead of $1,000.
Starting October 1, 2025, provider lists must be submitted through the Division’s CARDS system, set to launch next spring.
Three topics were selected, but the state may expand the scope of research to accommodate stakeholder suggestions.
As part of new changes to the medical fee schedule, this rule will take effect January 1, 2025.
Effective October 27th, these professionals can treat injured workers under the supervision of a Board-authorized provider.
Doctors performing utilization review for private employers will not have to be board certified.
